Mitsubishi UFJ Trust & Banking Corp Has $9.38 Million Stock Holdings in STERIS plc (NYSE:STE)

Mitsubishi UFJ Trust & Banking Corp lowered its holdings in STERIS plc (NYSE:STE - Free Report) by 2.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 45,617 shares of the medical equipment provider's stock after selling 1,322 shares during the period. Mitsubishi UFJ Trust & Banking Corp's holdings in STERIS were worth $9,377,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of STE. Avalon Trust Co bought a new stake in STERIS in the 4th quarter valued at about $30,000. Human Investing LLC bought a new stake in STERIS during the 4th quarter valued at $31,000. Anfield Capital Management LLC grew its stake in shares of STERIS by 100.0% in the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock worth $37,000 after purchasing an additional 91 shares in the last quarter. Central Pacific Bank Trust Division increased its stake in STERIS by 65.5% during the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock valued at $39,000 after buying an additional 76 shares during the period. Finally, Manchester Capital Management LLC increased its stake in shares of STERIS by 182.7% during the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock valued at $44,000 after acquiring an additional 137 shares during the period. 94.69% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

STE has been the subject of a number of research reports. Stephens reaffirmed an "overweight" rating and set a $240.00 price target on shares of STERIS in a research note on Thursday, February 6th. Piper Sandler raised their target price on STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research note on Monday, February 3rd. Finally, JMP Securities reiterated a "market outperform" rating and issued a $265.00 price target on shares of STERIS in a research report on Thursday, February 6th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, STERIS currently has a consensus rating of "Moderate Buy" and an average target price of $258.75.

Remove Ads

STERIS Price Performance

Shares of NYSE:STE traded down $4.02 on Thursday, reaching $223.55. 86,391 shares of the company traded hands, compared to its average volume of 527,977. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40. The stock has a market capitalization of $21.96 billion, a PE ratio of 47.46 and a beta of 0.92. The company's 50 day moving average is $223.22 and its 200-day moving average is $220.93. STERIS plc has a fifty-two week low of $197.82 and a fifty-two week high of $248.24.

STERIS (NYSE:STE - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. As a group, analysts anticipate that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were issued a dividend of $0.57 per share. This represents a $2.28 annualized dividend and a dividend yield of 1.02%. The ex-dividend date was Thursday, February 20th. STERIS's dividend payout ratio is currently 48.41%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.